Liposomal phytohemagglutinin: In vivo T‐cell activator as a novel pan‐cancer immunotherapy is a research paper published in Journal of Cellular and Molecular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Center for Advancing Translational Sciences
Grant: TL1TR002344
Foundation for the National Institutes of Health
Grant: P30CA091842
Foundation for the National Institutes of Health
Grant: P50CA094056
Foundation for the National Institutes of Health
Grant: U54CA199092
NCI NIH HHS
Grant: R01 CA260855
National Institutes of Health
Grant: 5P50CA094056-11
Res Proj 3: Imaging HTLV-1 Tax Induced Lymphomas
National Institutes of Health
Grant: 5TL1TR002344-03
Washington University Institute of Clinical and Translational Sciences (TL1)
National Institutes of Health
Grant: 5P30CA091842-05
Core--Pharmacology Facility
National Institutes of Health
Grant: 1U54CA199092-01
Developmental Project
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals